KLI

Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30?Expressing Non-Hodgkin Lymphomas:Results of a Multicenter, Open-Labeled Phase II Trial

Metadata Downloads
Publisher
CANCER RESEARCH AND TREATMENT
Language
영어
ISSN
1598-2998
Citation Volume
52
Citation Number
2
Citation Start Page
374
Citation End Page
387
Appears in Collections:
Medicine > Medicine
Authorize & License
  • Authorize공개
Files in This Item:
  • There are no files associated with this item.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.